GLP-1 coverage in Pennsylvania
Documented Medicaid fee-for-service status and insurance-mandate activity — not a decision for your member ID.
Sources last checked October 23, 2026
Spot an error? Report a correction
Medicaid (obesity / weight-loss)
KFF, "Medicaid Coverage of and Spending on GLP-1s", January 2026
This is the KFF January 2026 fee-for-service survey row for Pennsylvania. Managed-care plans in the same state can differ. GLP-1s prescribed for type 2 diabetes are covered by every state Medicaid program regardless of this row.
Pennsylvania Medicaid stopped covering GLP-1 drugs for overweight and obesity on January 1, 2026.
Pennsylvania Department of Human Services Medical Assistance Bulletin: GLP-1 receptor agonists "will not be covered for the treatment of overweight and obesity" effective January 1, 2026. Saxenda is no longer covered for any indication.
Source: PA DHS Medical Assistance Bulletin, Coverage Change and Prior Authorization of GLP-1 Receptor Agonists, 2025-11-24
All GLP-1 prescriptions now require prior authorization. Existing authorizations were not valid after December 31, 2025, and fills are limited to a one-month supply.
Source: PA DHS Medical Assistance Bulletin, Coverage Change and Prior Authorization of GLP-1 Receptor Agonists, 2025-11-24
KFF's survey of state Medicaid officials lists Pennsylvania among four states that eliminated GLP-1 coverage for obesity and among seven states that cover weight-loss drugs but no GLP-1s.
Source: KFF: Medicaid Coverage of and Spending on GLP-1s, 2026-01-16
The Pennsylvania Health Law Project reports that people under 21 may still get GLP-1s for weight loss under the federal EPSDT benefit when a prescriber requests authorization. This is the advocacy group's summary, not the DHS bulletin, which does not address under-21 exceptions.
Source: Pennsylvania Health Law Project, 2025-12-01
Diabetes
Other medically accepted uses stay covered with prior authorization. The DHS bulletin says GLP-1s "will continue to be covered for all other medically accepted indications with a prior authorization," which includes type 2 diabetes.
Source: PA DHS Medical Assistance Bulletin, Coverage Change and Prior Authorization of GLP-1 Receptor Agonists, 2025-11-24
State insurance-mandate activity
No mandate activity found in our current tracking for Pennsylvania. That is not a denial — in most cases your employer plan matters more than a state statute. Full list: state laws.
What to do with this
Medicaid survey rows and mandate bills are not a prior-authorization approval. Call the number on your ID card and ask whether the drug is covered for your diagnosis.
Full 5-step checklist →Related: All state pages · Medicaid by state · State laws · Cash-pay options